Wilmington, Delaware, United States, Aug. 09, 2023 (GLOBE NEWSWIRE) — The global chronic obstructive pulmonary disease (COPD) treatment market is projected to flourish at a CAGR of 4.4% from 2022 to 2031. As per the report published by TMR, a valuation of US$ 30.4 billion is anticipated for the market…Read More
Chronic Obstructive Pulmonary Disease COPD Treatment Market to reach USD 304 billion by 2031 expanding at a CAGR of 44 TMR Report
